Nifty
Sensex
:
:
22620.40
73730.16
50.05 (0.22%)
-609.28 (-0.82%)

Pharmaceuticals & Drugs - Global

Rating :
54/99

BSE: Not Listed | NSE: ZOTA

485.00
26-Apr-2024
  • Open
  • High
  • Low
  • Previous Close
  •  485.00
  •  491.00
  •  481.05
  •  486.40
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  14585
  •  70.80
  •  555.00
  •  271.95

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,286.55
  • N/A
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,284.74
  • 0.21%
  • 11.25

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 66.15%
  • 4.80%
  • 21.95%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 7.10%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 10.69
  • 10.32
  • 9.43

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 1.24
  • -2.96
  • 62.93

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 7.80
  • 3.49
  • 201.75

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 82.69
  • 78.75

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 8.21
  • 9.83

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 83.74
  • 99.57

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Mar 23
Mar 22
Var%
Net Sales
46.93
34.97
34.20%
45.27
38.95
16.23%
38.65
29.19
32.41%
36.85
31.34
17.58%
Expenses
43.60
34.94
24.79%
40.85
34.12
19.72%
37.37
27.75
34.67%
35.82
31.28
14.51%
EBITDA
3.33
0.03
11,000.00%
4.43
4.83
-8.28%
1.28
1.44
-11.11%
1.03
0.06
1,616.67%
EBIDTM
7.10%
0.08%
9.78%
12.41%
3.31%
4.94%
2.80%
0.18%
Other Income
0.15
0.62
-75.81%
0.40
0.84
-52.38%
0.15
0.47
-68.09%
0.03
0.81
-96.30%
Interest
1.14
0.71
60.56%
1.14
0.66
72.73%
0.83
0.38
118.42%
0.81
0.29
179.31%
Depreciation
5.08
3.30
53.94%
4.80
2.87
67.25%
3.41
1.91
78.53%
3.88
1.58
145.57%
PBT
-2.73
-3.37
-
-1.11
2.15
-
-2.81
-0.38
-
-3.09
-0.99
-
Tax
0.21
-0.14
-
0.54
1.24
-56.45%
0.03
0.44
-93.18%
-0.46
0.02
-
PAT
-2.94
-3.23
-
-1.65
0.91
-
-2.84
-0.82
-
-2.64
-1.01
-
PATM
-6.26%
-9.23%
-3.65%
2.32%
-7.35%
-2.80%
-7.15%
-3.23%
EPS
-1.14
-1.28
-
-0.64
0.36
-
-1.13
-0.33
-
-1.05
-0.40
-

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Net Sales
167.70
139.91
131.17
106.77
95.11
85.63
Net Sales Growth
24.73%
6.66%
22.85%
12.26%
11.07%
 
Cost Of Goods Sold
94.59
83.27
86.62
73.28
66.30
57.01
Gross Profit
73.11
56.64
44.55
33.48
28.81
28.62
GP Margin
43.59%
40.48%
33.96%
31.36%
30.29%
33.42%
Total Expenditure
157.64
133.25
116.73
106.19
90.60
77.89
Power & Fuel Cost
-
1.35
0.94
0.77
0.68
0.61
% Of Sales
-
0.96%
0.72%
0.72%
0.71%
0.71%
Employee Cost
-
12.15
9.48
8.56
9.59
8.02
% Of Sales
-
8.68%
7.23%
8.02%
10.08%
9.37%
Manufacturing Exp.
-
1.72
2.35
1.96
1.79
1.83
% Of Sales
-
1.23%
1.79%
1.84%
1.88%
2.14%
General & Admin Exp.
-
8.21
7.81
6.83
6.24
5.54
% Of Sales
-
5.87%
5.95%
6.40%
6.56%
6.47%
Selling & Distn. Exp.
-
26.38
9.47
14.62
5.83
4.46
% Of Sales
-
18.85%
7.22%
13.69%
6.13%
5.21%
Miscellaneous Exp.
-
0.16
0.07
0.16
0.18
0.41
% Of Sales
-
0.11%
0.05%
0.15%
0.19%
0.48%
EBITDA
10.07
6.66
14.44
0.58
4.51
7.74
EBITDA Margin
6.00%
4.76%
11.01%
0.54%
4.74%
9.04%
Other Income
0.73
2.62
1.99
1.31
1.52
1.54
Interest
3.92
2.56
0.32
0.11
0.07
0.04
Depreciation
17.17
11.96
3.67
3.17
2.10
1.39
PBT
-9.74
-5.23
12.43
-1.39
3.86
7.86
Tax
0.32
1.08
3.53
-0.16
1.12
2.31
Tax Rate
-3.29%
-23.03%
28.40%
44.44%
29.02%
29.39%
PAT
-10.07
-5.77
8.91
-0.21
2.74
5.55
PAT before Minority Interest
-10.07
-5.77
8.91
-0.21
2.74
5.55
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
-6.00%
-4.12%
6.79%
-0.20%
2.88%
6.48%
PAT Growth
0.00%
-
-
-
-50.63%
 
EPS
-3.90
-2.24
3.45
-0.08
1.06
2.15

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Shareholder's Funds
80.36
89.63
66.30
68.83
68.93
Share Capital
25.16
25.16
24.56
24.56
17.54
Total Reserves
55.20
64.47
41.74
44.27
51.38
Non-Current Liabilities
36.12
13.35
0.95
1.05
0.87
Secured Loans
0.00
0.00
0.00
0.00
0.00
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.98
1.04
0.94
0.87
0.76
Current Liabilities
40.52
35.96
18.23
18.60
19.81
Trade Payables
26.46
18.70
15.60
14.99
16.17
Other Current Liabilities
10.32
12.63
1.67
1.64
0.52
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
3.74
4.63
0.96
1.96
3.13
Total Liabilities
157.00
138.94
85.48
88.48
89.61
Net Block
62.08
29.10
14.08
15.41
9.78
Gross Block
92.85
47.91
29.93
28.09
20.36
Accumulated Depreciation
30.76
18.81
15.85
12.68
10.59
Non Current Assets
72.82
62.03
24.27
29.61
27.23
Capital Work in Progress
3.10
0.00
0.04
0.00
1.55
Non Current Investment
7.53
32.84
9.89
13.92
15.61
Long Term Loans & Adv.
0.11
0.09
0.27
0.28
0.29
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
Current Assets
84.17
76.90
61.21
58.86
62.37
Current Investments
0.00
0.00
0.00
0.00
0.00
Inventories
41.79
28.95
28.18
25.34
32.51
Sundry Debtors
27.83
36.37
28.77
29.14
22.10
Cash & Bank
1.12
2.30
1.35
0.83
1.69
Other Current Assets
13.44
0.94
0.66
0.28
6.07
Short Term Loans & Adv.
10.68
8.35
2.25
3.27
3.54
Net Current Assets
43.65
40.94
42.98
40.27
42.56
Total Assets
156.99
138.93
85.48
88.47
89.60

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Cash From Operating Activity
-2.01
13.33
-0.89
5.56
-3.25
PBT
-4.69
12.43
-0.37
3.86
7.86
Adjustment
13.12
2.66
1.45
1.06
0.01
Changes in Working Capital
-8.29
1.97
-1.91
1.73
-8.79
Cash after chg. in Working capital
0.13
17.07
-0.83
6.65
-0.93
Interest Paid
0.00
0.00
0.00
0.00
0.00
Tax Paid
-2.14
-3.73
-0.06
-1.10
-2.32
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
14.70
-26.65
3.82
-3.54
8.83
Net Fixed Assets
-4.41
-1.26
-1.79
-6.18
Net Investments
25.30
-24.85
4.04
1.59
Others
-6.19
-0.54
1.57
1.05
Cash from Financing Activity
-13.88
14.27
-2.42
-2.87
-6.35
Net Cash Inflow / Outflow
-1.18
0.95
0.51
-0.86
-0.77
Opening Cash & Equivalents
2.30
1.35
0.83
1.69
2.46
Closing Cash & Equivalent
1.12
2.30
1.35
0.83
1.69

Financial Ratios

Standalone /

Consolidated
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Book Value (Rs.)
31.94
35.62
26.99
28.02
28.06
ROA
-3.90%
7.94%
-0.24%
3.08%
6.19%
ROE
-6.79%
11.43%
-0.31%
3.98%
8.05%
ROCE
-2.50%
16.36%
-0.38%
5.71%
11.45%
Fixed Asset Turnover
1.99
3.37
3.68
3.93
4.21
Receivable days
83.71
90.61
98.96
98.30
94.19
Inventory Days
92.24
79.46
91.46
111.01
138.59
Payable days
98.97
72.26
76.17
85.77
72.36
Cash Conversion Cycle
76.98
97.82
114.25
123.54
160.41
Total Debt/Equity
0.00
0.00
0.00
0.00
0.00
Interest Cover
-0.83
39.77
-2.33
56.64
214.47

News Update:


  • Zota Health Care - Quarterly Results
    8th Feb 2024, 12:00 AM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.